pioglitazone has been researched along with Colitis Gravis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaefer, KL | 1 |
| Denevich, S | 1 |
| Ma, C | 1 |
| Cooley, SR | 1 |
| Nakajima, A | 1 |
| Wada, K | 1 |
| Schlezinger, J | 1 |
| Sherr, D | 1 |
| Saubermann, LJ | 1 |
1 other study available for pioglitazone and Colitis Gravis
| Article | Year |
|---|---|
Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms.
Topics: Animals; Chemokine CXCL10; Chemokines; Chemokines, CXC; Colitis, Ulcerative; Hypoglycemic Agents; In | 2005 |